[18F]PT-2385

N/A

Report date: 2025/11/27 15:48:12
NME

Base Information

Drug Name[18F]PT-2385
Drug Alias Name[18F]PT-2385
ClassificationSmall moleculesRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionPositron-emission tomography enhancersEndothelial PAS domain-containing protein 1 binders
TargetsEndothelial PAS domain-containing protein 1
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Texas Southwestern Medical Center
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A